Australia to trial backup COVID-19 vaccines that can be modified to fight virus mutations
SunSunday 3
Authorities hope the vaccinations on trial will be an alternative to the Pfizer-BioNTech COVID-19 vaccine.
(
Share
Print text only
Cancel
Researchers behind a clinical trial of two COVID-19 vaccines in Australia say they will be able to modify the vaccinations if mutations of the virus occur.
Key points:
Researchers say the mRNA-based vaccine and recombinant protein vaccine being trialled are more targeted
The Doherty Institute s Terry Nolan says it is vital Australia has its own vaccine to prevent supply chain issues
The trials have been expedited to mid-2021 with Federal Government funding
Our vaccines won’t arrive for three months, but there’s another problem with our ticket out of lockdown that two out of three people will need to overcome.
Our vaccines won’t arrive for three months, but there’s another problem with our ticket out of lockdown that two out of three people will need to overcome.
Our vaccines won’t arrive for three months, but there’s another problem with our ticket out of lockdown that two out of three people will need to overcome.
Pfizer, Moderna vaccines begin in US, UK as Australia faces huge challenge couriermail.com.au - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from couriermail.com.au Daily Mail and Mail on Sunday newspapers.